Skip to main content
. 2020 May 12;35(21):e139. doi: 10.3346/jkms.2020.35.e139

Table 3. Cox proportional hazard model of risk factors for cardiac involvement according to baseline variables.

Variables Model 1 Model 2 Model 3
HR 95% CI P value HR 95% CI P value HR 95% CI P value
Gender, ref: women 8.103 2.124–30.909 0.002 7.898 1.574–39.639 0.012 21.683 2.899–162.196 0.003
Age, yr 1.024 0.969–1.081 0.402 1.043 0.978–1.112 0.199 1.124 1.006–1.256 0.039
Anti-Sm antibody, ref: negative 6.211 1.545–24.974 0.010 10.219 1.931–54.090 0.006 17.746 2.132–147.675 0.008
Anti-Ro antibody, ref: negative 0.182 0.041–0.796 0.024 0.181 0.037–0.889 0.035 0.367 0.065–2.079 0.257
SDI, ref: SDI = 0 5.238 1.280–21.426 0.021 4.966 1.091–22.602 0.038 6.444 1.068–38.873 0.042
Smoking, ref: non-smoking 1.104 0.115–10.622 0.932 0.329 0.016–6.657 0.469
BMI, ref: normal 0.639 0.142–2.877 0.560 0.342 0.047–2.507 0.291
Hypertension, ref: absence 1.538 0.314 –7.540 0.595 1.487 0.211–10.495 0.691
Hyperlipidemia, ref: absence 0.476 0.050–4.497 0.517 0.171 0.007–4.364 0.285
Diabetes mellitus, ref: absence 2.473 0.487–12.547 0.275 1.492 0.214–10.495 0.686
Renal involvement, ref: absence 2.304 0.607–8.744 0.220 2.492 0.413–15.046 0.319
SELENA-SLEDAI 0.959 0.780–1.178 0.687
Anti-dsDNA antibody, ref: negative 6.123 0.560–66.908 0.137
Complement 3, mg/mL 1.004 0.951–1.060 0.882
Complement 4, mg/mL 1.006 0.904–1.120 0.908
Corticosteroid dose, mg/day 1.112 1.001–1.234 0.047
Hydroxychloroquine dose, mg/day 0.996 0.985–1.007 0.426

BMI = body mass index, SELENA-SLEDAI = safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index, SDI = Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index, HR = hazard ratio, CI = confidence interval.